E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for SFBC International Inc. > News item
Published on 2/3/2006 in the Prospect News Biotech Daily.

SFBC reiterated at buy

SFBC International, Inc. was reiterated by Jefferies & Co., Inc. analyst David Windley at a buy. Jefferies believes management is aggressively addressing risk issues and SFBC is winning new business. Shares of the Miami drug development company were up $2.37, or 10.31%, at $25.35 on volume of 3,360,087 shares versus the three-month running average of 2,656,590 shares. (Nasdaq: SFCC)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.